Abiopharma

🔍 Philip Amit (Executive)

Company: Lamb Weston Holdings, Inc. (LW)

Report Date: 2026-07-28

Detailed Transactions and Holdings:

• Acquired 8,788 shares of Common Stock (Direct)
  Date: 2026-07-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 38,686.30 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents restricted stock units ("RSUs") that vest 33%, 33% and 34% on August 3, 2027, August 1, 2028 and July 31, 2029, respectively, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston Holdings, Inc. common stock upon settlement.
• F2: Includes 267.3 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.